These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 20139035)
61. Isolation of 5-(hydroxymethyl)furfural from Lycium chinense and its inhibitory effect on the chemical mediator release by basophilic cells. Yamada P; Nemoto M; Shigemori H; Yokota S; Isoda H Planta Med; 2011 Mar; 77(5):434-40. PubMed ID: 21031336 [TBL] [Abstract][Full Text] [Related]
62. Membrane IgE binds and activates Fc epsilon RI in an antigen-independent manner. Vangelista L; Soprana E; Cesco-Gaspere M; Mandiola P; Di Lullo G; Fucci RN; Codazzi F; Palini A; Paganelli G; Burrone OR; Siccardi AG J Immunol; 2005 May; 174(9):5602-11. PubMed ID: 15843559 [TBL] [Abstract][Full Text] [Related]
63. Different Results of IgE Binding- and Crosslinking-Based Allergy Tests Caused by Allergen Immobilization. Okamoto-Uchida Y; Nakamura R; Matsuzawa Y; Soma M; Kawakami H; Ishii-Watabe A; Nishimaki-Mogami T; Teshima R; Saito Y Biol Pharm Bull; 2016; 39(10):1662-1666. PubMed ID: 27725443 [TBL] [Abstract][Full Text] [Related]
64. Synthesis of norlignans and in vitro inhibitory activity of antigen-induced degranulation. Park E; Yang YJ; Kim A; Kwak JH; Jung YH; Kang SC; Kim IS Bioorg Med Chem Lett; 2012 Jun; 22(11):3653-5. PubMed ID: 22543029 [TBL] [Abstract][Full Text] [Related]
65. Activation of Human Peripheral Basophils in Response to High IgE Antibody Concentrations without Antigens. Yanase Y; Matsuo Y; Kawaguchi T; Ishii K; Tanaka A; Iwamoto K; Takahagi S; Hide M Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30583496 [TBL] [Abstract][Full Text] [Related]
66. Response of FcεRI-bearing leucocytes to omalizumab in chronic spontaneous urticaria. Alizadeh Aghdam M; Knol EF; van den Elzen M; den Hartog Jager C; van Os-Medendorp H; Knulst AC; Otten HG; Röckmann H Clin Exp Allergy; 2020 Mar; 50(3):364-371. PubMed ID: 31925825 [TBL] [Abstract][Full Text] [Related]
67. Identification of amino acid residues involved in the interaction of canine IgE with canine and human FcεRIα. Ye H; Housden JE; Hunter M; Sabban S; Helm BA Mol Immunol; 2014 Feb; 57(2):111-8. PubMed ID: 24084098 [TBL] [Abstract][Full Text] [Related]
68. Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI. Sabban S; Ye H; Helm B J Vis Exp; 2014 Nov; (93):e52222. PubMed ID: 25406512 [TBL] [Abstract][Full Text] [Related]
69. Structural basis for selective inhibition of immunoglobulin E-receptor interactions by an anti-IgE antibody. Chen JB; Ramadani F; Pang MOY; Beavil RL; Holdom MD; Mitropoulou AN; Beavil AJ; Gould HJ; Chang TW; Sutton BJ; McDonnell JM; Davies AM Sci Rep; 2018 Aug; 8(1):11548. PubMed ID: 30069035 [TBL] [Abstract][Full Text] [Related]
70. Allergen Valency, Dose, and FcεRI Occupancy Set Thresholds for Secretory Responses to Pen a 1 and Motivate Design of Hypoallergens. Mahajan A; Youssef LA; Cleyrat C; Grattan R; Lucero SR; Mattison CP; Erasmus MF; Jacobson B; Tapia L; Hlavacek WS; Schuyler M; Wilson BS J Immunol; 2017 Feb; 198(3):1034-1046. PubMed ID: 28039304 [TBL] [Abstract][Full Text] [Related]
71. Structure of the omalizumab Fab. Jensen RK; Plum M; Tjerrild L; Jakob T; Spillner E; Andersen GR Acta Crystallogr F Struct Biol Commun; 2015 Apr; 71(Pt 4):419-26. PubMed ID: 25849503 [TBL] [Abstract][Full Text] [Related]
72. IgE and high-affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance. Giménez-Arnau AM; Ribas-Llauradó C; Mohammad-Porras N; Deza G; Pujol RM; Gimeno R Clin Transl Allergy; 2022 Feb; 12(2):e12117. PubMed ID: 35126995 [TBL] [Abstract][Full Text] [Related]
73. Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab. Davies AM; Allan EG; Keeble AH; Delgado J; Cossins BP; Mitropoulou AN; Pang MOY; Ceska T; Beavil AJ; Craggs G; Westwood M; Henry AJ; McDonnell JM; Sutton BJ J Biol Chem; 2017 Jun; 292(24):9975-9987. PubMed ID: 28438838 [TBL] [Abstract][Full Text] [Related]
74. Characterization of complex formation by humanized anti-IgE monoclonal antibody and monoclonal human IgE. Liu J; Lester P; Builder S; Shire SJ Biochemistry; 1995 Aug; 34(33):10474-82. PubMed ID: 7654701 [TBL] [Abstract][Full Text] [Related]
75. Application of human Fc epsilon RI alpha-chain-transfected RBL-2H3 cells for estimation of active serum IgE. Takagi K; Nakamura R; Teshima R; Sawada J Biol Pharm Bull; 2003 Feb; 26(2):252-5. PubMed ID: 12576689 [TBL] [Abstract][Full Text] [Related]
76. Fluorogen-activating proteins provide tunable labeling densities for tracking FcεRI independent of IgE. Schwartz SL; Yan Q; Telmer CA; Lidke KA; Bruchez MP; Lidke DS ACS Chem Biol; 2015 Feb; 10(2):539-46. PubMed ID: 25343439 [TBL] [Abstract][Full Text] [Related]
77. Monomeric immunoglobulin E stabilizes FcepsilonRIalpha from the human basophil cell line KU812 by protecting it from natural turnover. Jensen BM; Hansen JB; Dissing S; Gerwien J; Skov PS; Poulsen LK Clin Exp Allergy; 2003 May; 33(5):655-62. PubMed ID: 12752595 [TBL] [Abstract][Full Text] [Related]
78. Ligelizumab impairs IgE-binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN-α production and FOXP3 Benito-Villalvilla C; de la Rocha-Muñoz A; López-Abente J; Eggel A; Bottoli I; Severin T; Woisetschläger M; Palomares O Allergy; 2023 Apr; 78(4):1060-1072. PubMed ID: 36315052 [TBL] [Abstract][Full Text] [Related]
79. Characterization of modified allergen extracts by in vitro beta-hexosaminidase release from rat basophils. Gehlhar K; Peters M; Brockmann K; van Schijndel H; Bufe A Int Arch Allergy Immunol; 2005 Apr; 136(4):311-9. PubMed ID: 15722642 [TBL] [Abstract][Full Text] [Related]
80. Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor. Kim B; Eggel A; Tarchevskaya SS; Vogel M; Prinz H; Jardetzky TS Nature; 2012 Nov; 491(7425):613-7. PubMed ID: 23103871 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]